From Bench to Breakthrough: Empowering the Next Generation of Science CommunicatorsMorningStar·18 hours agoMKKGY+2.80%MRK
Merck KGaA (XTRA:MRK) Could Be 5% Undervalued Following Its BioReliance Facility OpeningSimplywall·Jul 18 at 08:03 PMMKKGY+2.80%MRK
EC approves Erbitux combination for first‑line treatment of BRAF V600E‑mutant mCRCPharmaTimes·Jul 14 at 05:52 AMMRK
Merck KGaA (OTCMKTS:MKKGY) Sees Significant Decline in Short InterestMarket Beat·Jul 13 at 08:20 AMMKKGY+2.80%MRK
Bio-Techne (TECH) Launches AI Proteins As Valuation Questions Come Back Into FocusSimplywall·Jul 8 at 07:08 PMTECH-7.00%MKKGY+2.80%
Merck KGaA says FDA grants breakthrough designation to lupus drug enpatoranPUBT·Jul 8 at 07:04 AMMRKMKKGY+2.80%
Merck KGaA (XTRA:MRK) Expands Into Precision Cardiology, Is The Upside Already Priced In?Simplywall·Jul 3 at 03:07 PMMRK
Merck calls EUR 1 billion subordinated notes for redemption on Sept. 9, 2026PUBT·Jul 1 at 04:14 AMMRKMKKGY+2.80%
Key facts: Merck KGaA to Buy Bio-Techne; Break Fees $576M/$230MTradingView·Jun 27 at 12:13 AMTECH-7.00%MRK
14:24 ETSHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Bio-Techne Corporation (NASDAQ: TECH)prnewswire·Jun 26 at 01:25 PMTECH-7.00%MRK
